Zobrazeno 1 - 10
of 61
pro vyhledávání: '"V, Evrard"'
Publikováno v:
L'Encéphale. 39:29-37
Resume Les objectifs de cette etude etaient, dans une population de 49 jeunes enfants âges de trois a 30 mois presentant des troubles fonctionnels (TF) et/ou du comportement, d’evaluer apres une intervention therapeutique breve l’evolution de l
Autor:
Bernard Guillot, Brigitte Dréno, Michèle Delaunay, J‐L. Verret, P. Foulc, Sophie Dalac, V. Evrard
Publikováno v:
British Journal of Dermatology. 147:926-930
SummaryBackground Mechlorethamine is frequently used in the treatment of cutaneous lymphoma, but its application is limited in 30–80% of cases because of cutaneous intolerance. Reducing the concentration to avoid this side-effect has been only mode
Autor:
Brigitte Crispin, V. Evrard, Raymond Reding, Ch. Saint-Martin, Jean-Bernard Otte, J P Buts, Ph. Clapuyt, Yves Castille, François-Xavier Wese, N. Jodogne, J.A Serrano
Publikováno v:
Acta Endoscopica. 31:649-658
L'incidence des malformations anorectales est de 1/5 000 naissances. Il s'agit d'un spectre de malformations, classees en formes basses ou hautes en fonction de leurs caracteristiques anatomiques et du pronostic de continence fecale chez le patient a
Publikováno v:
L'Encephale. 39(1)
Functional and behavioral disorders are the most frequent reasons for consultation in infant psychiatry, but there are still few studies about the efficacy of parents-child psychotherapies. Functional disorders appear to be easier to treat than behav
Publikováno v:
European Child & Adolescent Psychiatry
European Child and Adolescent Psychiatry
European Child and Adolescent Psychiatry, Springer Verlag (Germany), 2009, 18 (12), pp.737-746. ⟨10.1007/s00787-009-0032-9⟩
European Child and Adolescent Psychiatry
European Child and Adolescent Psychiatry, Springer Verlag (Germany), 2009, 18 (12), pp.737-746. ⟨10.1007/s00787-009-0032-9⟩
International audience; The efficacy of parent–child psychotherapies is widely recognized today. There are, however, less data on predictive factors for outcome in infants and toddlers and their parents. The aim of this study was to highlight predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5d2d3c6c73d4a43fe820c42d2ca6f0
http://www.ssoar.info/ssoar/handle/document/20284
http://www.ssoar.info/ssoar/handle/document/20284
Autor:
Ian Judson, V. Evrard, Jaap Verweij, C. Seynaeve, J. Jimeno, Pancras C.W. Hogendoorn, A. Le Cesne, Sylvie Bonvalot, Jean-Yves Blay, M. van Glabbeke, Michelle Scurr
Publikováno v:
European Journal of Cancer, 40, 1327-1331. Elsevier Ltd.
A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours Primary or secondary resistance to imatinib may occur in patients with gastrointestinal stromal tumours (GISTs) while these tumours have r
Autor:
R, Reding, C, Bourdeaux, J, Gras, V, Evrard, J P, Buts, M, Carlier, O, Ciccarelli, P, Clapuyt, S Clement, de Clety, M, De Kock, D, Hermans, M, Janssen, D, Moulin, J, Rahier, C, Saint-Martin, C, Sempoux, L, Van Obbergh, F, Veyckemans, J, Lerut, J, de Ville de Goyet, E, Sokal, J B, Otte
The Paediatric Liver Transplant Program at Saint-Luc University Clinics constitutes a substantial single centre experience, including 667 transplantations performed between March 1984 and April 2003, and the history of this program reflects the treme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e3a33139b061326d3d7fedbe0fe7a7ef
http://hdl.handle.net/2108/60510
http://hdl.handle.net/2108/60510
Publikováno v:
Transplantation. 75(10)
The purpose of this study was to assess the overall results of recipients undergoing transplantation for biliary atresia (BA), according to age, surgical techniques, and transplant eras, and to identify the prognostic factors affecting outcome.Betwee
Autor:
V. Evrard, Jaap Verweij, A. Le Cesne, M. van Glabbeke, Peter Reichardt, Ian Judson, J.-Y. Blay, Rolf D. Issels, John Zalcberg, Paolo G. Casali
Publikováno v:
Journal of Clinical Oncology. 22:9004-9004
9004 Background: The EORTC-ISG-AGITG trial in which 946 GIST patients (pts) were randomized to receive 400 or 800 mg of Imatinib daily has shown an increased progression free survival in pts randomized to the HD arm. Pts randomized to LD could cross-
Autor:
V. Evrard, Jaap Verweij, J.-Y. Blay, Florence Duffaud, P.C.W. Hogendoorn, A. Le Cesne, M. G. Leahy, Ian Judson, C. de Balincourt
Publikováno v:
European Journal of Cancer Supplements. 1:S209